FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/06/2022
Voltar para busca
Dado oficial do USPTO
DIACEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
DIACEUTICS
ST13
US500000079297749Classe
5, 9, 35, 42
Pedido
79297749
Registro
6578393
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
12/06/2022
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 35, 42
Data de depósito
15/09/2020
Data de registro
07/12/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/12/2021
Última transação
07/12/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
LAWRENCE, SUE
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Diaceutics Plc
Representantes
MARGARET M. POWERS SHAY GLENN LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic testing materials in the nature of reagents for medical use; Medical diagnostic reagents and assays for testing of body fluids; Reagents for use in diagnostic tests for medical purposes
Classe 9
Downloadable computer software used in respect of medicine and pharmaceutical research and development services for data managementdata analysisdata manipulation; downloadable computer software used to connect laboratory networks and diagnostic and pharmaceutical companies; downloadable computer software used to analyse data; downloadable computer software for use in relation to business networking and content management; downloadable computer software applications delivered to any computing device including desktoplaptop and tablet computers as well as mobile devices for data management and visualisationfor generating reportscharts and dashboards
Classe 35
Business consultancy and advisory services; provision of business information and business management services to laboratory networks and diagnostic and pharmaceutical companies; compilation of informationstatistics and data into computer databases relating to medicine and pharmaceutical testingresearch and development services; business data analysis; advisory and consultancy services relating to business intelligence and business industry research; compilation of information into computer databases; providing information regarding business intelligence and business industry research via a website
Classe 42
Pharmaceutical drug development services; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; medical research relating to medicines; testing of pharmaceuticals; computer aided diagnostic testing servicescomputer-aided diagnostic product testing; design and development of medical diagnostic apparatus; research and development in the field of medical diagnostic preparations; design and development of computer databases; design services relating to data processing test tools; provision of information and data relating to medical and veterinary research and development; technical data analysis servicesdata analysis for medicine and pharmaceutical testingresearch and development purposes; software as a service (SaaS) services featuring non-downloadable software for data managementdata analysisdata manipulationmedicine and pharmaceutical testingresearch and development services; software as a service (SaaS) services featuring non-downloadable software enabling communication between laboratory networks and diagnostic and pharmaceutical companies; software as a service (SaaS) services featuring non-downloadable software for data management and visualisationincluding generating reportscharts and dashboards; platform as a service (PaaS) services featuring non-downloadable software platforms for data managementdata analysisdata manipulationmedicine and pharmaceutical testingresearch and development services; platform as a service (PaaS) services featuring non-downloadable software platforms enabling communication between laboratory networks and diagnostic and pharmaceutical companies; platform as a service (PaaS) services featuring non-downloadable software platforms for data management and visualisationincluding generating reportscharts and dashboards; informationadvice and consultancy in relation to all the aforesaid services
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
23/05/2022
FIMP
FINAL DISPOSITION PROCESSED
23/05/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/03/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
07/12/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
26/10/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/09/2021
PUBO
PUBLISHED FOR OPPOSITION
21/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/09/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/08/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/07/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/07/2021
RFNT
REFUSAL PROCESSED BY IB
01/03/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/02/2021
RFRR
REFUSAL PROCESSED BY MPU
06/02/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
23/01/2021
CNRT
NON-FINAL ACTION WRITTEN
22/01/2021
DOCK
ASSIGNED TO EXAMINER
21/01/2021
MAFR
APPLICATION FILING RECEIPT MAILED
20/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/11/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/11/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace DIACEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.